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Introduction: CASP speciﬁcally assesses post-stroke cognitive impairments. Its items are visual and as
such can be administered to patients with severe expressive aphasia. We have previously shown that the
CASP was more suitable than the Mini Mental State Examination (MMSE) and Montreal Cognitive
Assessment (MoCA) in aphasic patients. Our objective was to compare the above scales in non-aphasic
stroke patients, and assess to what extent the solely visual items of the CASP were problematic in cases of
neurovisual impairments.
Methods: Fifty non-aphasic patients admitted to Physical Medicine and Rehabilitation (PM&R) units after
a recent left- or right-hemisphere stroke were evaluated with the CASP, MMSE and MoCA. We compared
these three scales in terms of feasibility, concordance, and inﬂuence of neurovisual impairments on the
total score.
Results: Twenty-nine men and 21 women were included (mean age 63  14). For three patients, the MoCa
was impossible to administer. It took signiﬁcantly less time to administer the CASP (10  5 min) than the
MoCA (11  5 min, P = 0.02), yet it still took more time than MMSE administration (7  3 min, P < 106).
Neurovisual impairments affected equally the total scores of the three tests. Concordance between these
scores was poor and only the CASP could speciﬁcally assess unilateral spatial neglect.
Conclusion: The sole visual format of the CASP scale seems suitable for administration in post-stroke
patients.
 2015 Elsevier Masson SAS. All rights reserved.
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The relevance of assessing cognitive impairments early on after
stroke has been largely validated. Several batteries of tests are used
in clinical practice today, regardless of having been previously
validated for that speciﬁc use. In a recent work [3,4], we reported
the main assessments scales for cognitive disorders and demon-
strated the superiority of the Cognitive Assessment scale for Stroke
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[5,6] and MoCA (Montre´al Cognitive Assessment) [11] in terms of
feasibility in a population of post-stroke aphasic patients. As a
matter of fact, the CASP was speciﬁcally designed, both in terms of
content and format, for a quick evaluation of post-stroke cognitive
disorders at ‘‘the patient’s bedside’’. Its main characteristics consist
in (see details in the primary publication by Barnay et al., [4]):
 six cognitive functions being evaluated: language, praxis, short-
term memory, temporal orientation, spatial neglect/visual
construction, executive functions (Appendix 1);
 each of the six functions is scored on a scale of 6 (equal weight
attributed to each function). The score is expressed either as a
proﬁle (i.e. ‘‘5-6-4-2-3-4’’), or as a total score out of 36;
 patients can answer the tests without using language (solely
visual tests or designating the right answer among distractors).
The CASP can be administered to patients with mutism as long as
they retained some oral comprehension for simple orders (BDAE
aphasia severity score  3 for the comprehension dimension
[7,10]);
 elements from the test that the patient must look at are
systematically ordered in a column and/or placed on the right
side of the test sheet to minimize the inﬂuence of left unilateral
spatial neglect;
 it is the only short cognitive evaluation battery containing a test
validated speciﬁcally for spatial neglect, issued from the French
unilateral neglect battery BEN (Batterie d’Evaluation de la
Ne´gligence) (20-cm horizontal line bisection test) [2];
 shorter administration time in aphasic patients (13  4 min).
In our ﬁrst study we were able to note that when MMSE and
MoCA could not be administered to several aphasic patients, it was
however possible to administer the CASP in these patients. For
other patients, results to the MMSE and MoCA tests evaluating
non-language functions were highly inﬂuenced by the severity of
aphasia, signiﬁcantly more than for the CASP. Therefore, with the
CASP we observed (in this work and in our daily clinical practice)
that a signiﬁcant portion of aphasic patients retained a pretty good
orientation to time, an element impossible to verify with the
MMSE and MoCA. However, in this study, we experienced great
difﬁculties in administering the CASP in at least one patient
presenting major neurovisual impairments (cortical blindness).
This observation was expected since CASP items are solely visual-
related.
Of course, CASP relevance would be quite limited if it was
restricted to aphasic patients (this is why we took into account a
possible left spatial neglect in designing the test). The objectives of
the present study were to validate the applicability of CASP in non-
aphasic stroke patients, assess the inﬂuence of neurovisual
disorders on CASP administration, and compare CASP scores to
those of the MMSE and MoCA.
2. Patients and methods
During 2013, we recruited ﬁfty patients consecutively admitted
in seven PM&R units for recent primary hemispheric stroke
without aphasia. They all beneﬁted from the systematic adminis-
tration of the CASP, MMSE and MoCA. The study consisted in:
 estimating the percentage of patients for whom the administra-
tion of one or several items of these three scales was impossible;
 comparing the mean administration time of the tests;
 evaluating in each battery of tests the inﬂuence of neurovisual
impairments on the total score (outside of neurovisual items);
 comparing the scores of the three batteries.2.1. Inclusion criteria
Patients hospitalized in a rehabilitation unit during the ﬁrst
100 days following a primary stroke affecting the left and/or right
hemisphere, not presenting with aphasia, without any restriction
in terms of age or severity of cognitive disorders.
2.2. Exclusion criteria
Consciousness disorders, patients not speaking French, cogni-
tive, psychotic or visual disorders, not compatible with reading,
which were known prior to the stroke, stroke-induced language
impairments (BDAE aphasia severity score between 0 and 5).
2.3. Administration of the three tests
According to the local context, the tests could be administered
by a physician, a resident, a speech therapist, or a neuropsycholo-
gist. The order in which the three tests were administered was
decided in advance by random drawing. For each patient, one
unique examiner had to administer the three tests.
2.4. Collected data
Scores and administration times of the three scales were noted.
Scores for items exploring neurovisual functions were calculated
separately for each scale: sum of item 3 (copy of a cube) and item 6
(line bisection), on 6 points for the CASP; item 6 (reproduction of a
drawing), on 1 point for the MMSE; item 1 (drawing letters/
numbers to connect + reproducing a cube + watch test), on 5 points
for the MoCA. General demographic data and stroke characteristics
were collected.
2.5. Data treatment
The comparison of mean administration times between the
three batteries was evaluated by the non-parametric Wilcoxon
signed-rank test (assumptions and conditions for the paired two-
sample t-test were not satisﬁed). The inﬂuence of the neurovisual
items on the total scores (outside of neurovisual items) was
assessed with the Pearson product-moment correlation coefﬁcient
(for correlation) and the intraclass correlation coefﬁcient (ICC) (for
concordance). In order to evaluate how the line bisection test
(CASP6) yielded speciﬁc information, a Principal component
analysis (PCA) was conducted using all neurovisual tests from
the three batteries. All statistics computations were conducted
with the Number Cruncher Statistical System 9 software [8].
3. Results
The ﬁfty patients planned for the protocol were included over a
4-month period (29 men/21 women). Mean age 63  14 years
(Ranges: 30–88), 44 were right-handed (88%), 4 were left-handed
(8%), and 2 were ambidextrous (4%). Brain damage concerned the
right hemisphere for 37 patients (74%), there was never bilateral
damage, the stroke was ischemic for 38 patients (76%), hemorrhagic
for 11 patients (22%), ischemic and hemorrhagic in 1 case (2%). Time
since stroke was 40  17 days (Ranges: 13–99).
3.1. Administration of the three batteries
The results of the administration of the three batteries are listed
in Table 1. Three patients were unable to pass the ﬁrst item of
the MoCA (‘‘visuospatial/executive’’ item). Among these three
patients, none obtained the maximum scores on the neurovisual
tests of the other two batteries. One of them was among the
Table 1
For the three batteries, number of complete and incomplete test administrations,
score and administration time.
Battery Incomplete test
administrations
Complete test administrations
Number (%) Scores Times (min)
CASP (/36) 0 (0) 29  5 (15.5–36) 10  5 (3–40)
MMSE (/30) 0 (0) 25  4 (13–30) 7  3 (3–20)
MoCA (/30) 3 (6) 21  5 (8–28) 11  5 (5–32)
CASP: Cognitive Assessment scale for Stroke Patients; MMSE: Mini Mental State
Examination; MoCA: Montreal Cognitive Assessment.
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Fig. 1. Principal component analysis (PCA) run with neurovisual items of the three
batteries. The ﬁrst principal component (Axis 1) is strongly correlated with items
CASP3, MMSE6 and MoCA1. The second component (Axis 2) is strongly correlated
with item CASP6 (line bisection test).
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scores were 29  5/36 for the CASP, 25  4/30 for the MMSE and
21  5/30 for the MoCA. The scores were not signiﬁcantly inﬂuenced
by time since stroke (‘‘r’’ values between 0.02 and 0.19, P > 0.20).
Mean administration time for the CASP (10  5 min) was signiﬁcantly
shorter than for the MoCA (11  5 min, P < 0.02) and signiﬁcantly
longer than for the MMSE (7  3 min, P < 106). These mean
administration times were not signiﬁcantly inﬂuenced by time since
stroke (‘‘r’’ values between 0.17 and 0.01, P > 0.20).
3.2. Inﬂuence of neurovisual disorders on total scores’ performance
(outside of neurovisual items)
In each battery, the score for the item (or items) testing
neurovisual functions was: (1) positively correlated to other items
of the battery. The three ‘‘r’’ values were similar: r = 0.41, P = 0.003;
r = 0.34, P = 0.015; r = 0.39, P = 0.007, respectively for the CASP,
MMSE and MoCA; and (2) negatively correlated to the adminis-
tration time of the complete battery for the CASP (r = 0.32,
P < 0.03) and for the MMSE (r = 0.32, P < 0.03), but not for the
MoCA (r = 0.15, P > 0.32). Four patients did not obtain the
maximum score at the CASP1 item for image naming. The patient
TOU5 obtained a score of 2/3 for this item, yet he had obtained
the maximum score to the ‘‘language’’ items of the other two
batteries. Since he obtained poor scores to the purely neurovisual
items of the three batteries, one can imagine that the purely
visual aspect of the CASP image naming test might have disrupted
his comprehension; patients GRE6 and GRE12 (2/3 and 2.5/3 to
CASP1) also failed to answer most items of the three batteries; and
ﬁnally patient CCR5 (2/3 to CASP1) obtained good scores
otherwise.
3.3. Relationship between the scores of the three batteries
The three scores were signiﬁcantly correlated with one another
(r > 0.69, P < 106 for the three paired comparisons), but their
concordance was moderate: ICC at 0.734 [0.579–0.837] between
CASP and MMSE, 0.590 [0.404–0.728] between CASP and MoCA,
and 0.579 [0.423–0.701] between MMSE and MoCA.
3.4. Information yielded by the line bisection test (CASP6)
The PCA was conducted with the neurovisual items of the three
batteries. Two main factors represented more than 79% of the
information. The ﬁrst factor (57% of the information) was mainly
correlated with the CASP3 (r = 0.82), MMSE6 (r = 0.79) and MoCA1
(r = 0.87). The second factor (22% of the information) was mostly
correlated to the CASP6 (r = 0.84). The circle of correlations can
appreciate the statistical distance between these four items
(Fig. 1). The PCA correlation table yielded values between
0.51 and 0.60 for correlations between the CASP3, MMSE6 and
MoCA1. Correlation coefﬁcients between these three items and the
CASP6 were lower, ranging between 0.15 and 0.38.4. Discussion
The CASP was designed for evaluating post-stroke cognitive
impairments at the patient’s bedside. In a previous work, we
reported that: (1) its administration was better suited to patients
with severe oral expression disorders and moderate comprehen-
sion disorders than the MMSE and MoCA and (2) its total score
(outside of language items) was 50% less inﬂuenced by aphasia
severity than those of the MMSE and MoCA [4]. The present work
focused on a population of non-aphasic patients, 75% of them had a
right-hemisphere stroke. The CASP could be administered in its
entirety to all patients, including those with spatial neglect,
screened via a line bisection test. The only administration failures
concerned the MoCA item that explored both executive and
neurovisual functions.
Mean administration time for CASP was 10 minutes, an
intermediate time between those of the MMSE and MoCA, thus
compatible with a quick assessment of cognitive disorders. It was
not statistically correlated to time since stroke (even if the
Pearson’s ‘‘r’’ coefﬁcients were, in all logic, negative). Furthermore,
time since stroke did not inﬂuence battery scores (even if the
Pearson’s ‘‘r’’ coefﬁcients were, in all logic, positive). These results
do not imply that all three batteries are not responsive enough
to clinical changes. They simply showed that there was a wide
diversity in the severity of cognitive impairments for our patients.
A study on the responsiveness to change of these three batteries is
planned in the very near future on a new cohort of patients who
will be examined twice during the ﬁrst trimester post-stroke.
We had expected that patients with major neurovisual
disorders would be disturbed by the purely visual aspect of the
items of the CASP, exploring other impairments. This was probably
the case for at least one of our patients, for the image naming items
CASP1 (he still obtained a score of 2 points out of 3 for this item).
Furthermore, we observed that the presence of neurovisual
disorders had a similar impact on the total score of the three
batteries. However, it had a signiﬁcantly greater impact on the
administration time of the CASP and MMSE than the MoCA. This
last result was expected for the CASP, but not for the MMSE which
only includes one visual item (MMSE6: reproduction of drawings).
Finally, we can consider that the visual aspect of the CASP only had
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previously demonstrated in left-hemispheric aphasic stroke
patients. We did not initially expect the following element when
we elaborated the CASP, but the examiner could, when relevant for
certain patients, adapt some visual test of the CASP by replacing
images by words (‘‘memory’’ test) or interview patients verbally
rather than propose multiple-choice written answers (‘‘calendar’’
item).
In the present study, similarly to the previous one, the three
scores were highly correlated with one another. This result was
expected a priori as previously shown by Aggarwal for the MMSE
and MoCA in a rehabilitation setting [1]. In his study, Aggarwal
only calculated Pearson’s ‘‘r’’ coefﬁcient (null hypothesis ‘‘H0: no
relationship between both scores’’), even though no indication was
given on the real concordance between both scores. In this study
the concordance was moderate. This result was predictable
because of the structural differences between the three batteries.
For example, the MMSE gives more importance to the ‘‘orientation’’
item (10 points/30 = 1/3) than the CASP (6 points/36 = 1/6) and
MoCA (6 points/30 = 1/5). Conversely, the only neurovisual item of
the MMSE (reproduction of a drawing) has much less impact on the
total score (1 point/30) than neurovisual items from the CASP
(6 points/36) and MoCA (5 points/30). Furthermore, gestural praxis
and unilateral spatial neglect are only tested in the CASP battery.
Thus, it is natural for the concordance to be poor between these
three batteries since they do not evaluate exactly the same
impairments and do not give the same importance to the different
functions.
Furthermore, like in any other clinical scale assessing different
impairments, computing the sub-scores into one unique score is
quite limiting by nature. For this reason, and contrarily to choices
made by the authors of the MMSE and MoCA, we gave the same
importance of 6 points/36 to the six functions evaluated and
suggested that clinicians use the ‘‘proﬁle’’ form of the score (‘‘5/4/
6/3/1/4’’), in addition to the total score.
Unilateral spatial neglect is a relatively common impairment
post-stroke, especially after right-hemispheric damage. Even if it
can disrupt the completion of the neurovisual items of the MMSE
and MoCA, it is not speciﬁcally evaluated. We included in the CASP
a line bisection test, previously validated for assessing spatial
neglect [2]. Our results suggest that the bisection item yields
speciﬁc information, insufﬁciently taken into account by the otherneurovisual items of the three batteries. This validates our choice
of having included an item speciﬁcally evaluating spatial neglect
within the CASP.
Even if the structure of the CASP seems better suited than those
of the MMSE and MoCA in post-stroke patients (especially in
aphasic patients), it is not possible today to conﬁrm its superiority
in terms of screening for cognitive disorders. In order to do so we
would have to complete our study by the concomitant adminis-
tration of these three tests along with a gold standard test in a new
group of patients.
5. Conclusion
In daily clinical practice, just like in clinical research, evaluating
cognitive disorders post-stroke is quite complex. The CASP was
designed for non-expert examiners to evaluate at ‘‘the patient’s
bedside’’, six cognitive functions commonly impaired post-stroke.
We reported in a previous study that its aspect, almost essentially
consisting of visual items, was well adapted to aphasic patients
(predominant motor aphasia). Elaborating a battery of cognitive
evaluation tests to be used in these patients was in fact our ﬁrst
motivation, knowing that aphasia is a very common impairment
post-stroke [9]. The present study shows that the administration of
the test is rarely impossible in patients with severe neurovisual
disorders. Thus, the format of the CASP seems globally better suited
than the MMSE or MoCA in stroke patients. Its psychometric
properties remain to be studied, a national PHRC (Hospital Project
of Clinical Research) is ongoing. This PHRC includes an analysis of
the validity, reliability and responsiveness to change for the CASP,
the setting of standards by age range and the comparison to the
MMSE and MoCa in terms of screening for cognitive disorders.
Furthermore, systematic data collection on the location of brain
damage will enable histoclinical correlation studies.
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